Here are four takeaways:
1. CU Innovations collaborates with CU researchers to help bring concepts to market.
2. TranS1 will serve as an industry partner, providing concept evaluation and assisting with product development.
3. The partnership will hone in on spinal health innovation, leveraging TranS1’s research and development portfolio.
4. TranS1 believes in surgeon-led innovation, helping surgeons turn their concepts into medical devices.
More articles on devices:
Stanford University Accuro trial sees positive results: 7 insights
Zimmer Biomet, Medtronic, Integra LifeSciences & more: 17 device company notes
The Anand Spine Group 1 of 30 spine centers participating in Premia Spine’s TOPS System study — 5 highlights
